Published in Ophthalmology on May 01, 2005
Failure to preserve beta-cell function with mycophenolate mofetil and daclizumab combined therapy in patients with new- onset type 1 diabetes. Diabetes Care (2010) 2.57
Effects of exenatide alone and in combination with daclizumab on beta-cell function in long-standing type 1 diabetes. Diabetes Care (2009) 2.02
The role of anti-inflammatory agents in age-related macular degeneration (AMD) treatment. Eye (Lond) (2010) 1.29
Emerging drugs for uveitis. Expert Opin Emerg Drugs (2011) 1.08
High-dose daclizumab for the treatment of juvenile idiopathic arthritis-associated active anterior uveitis. Am J Ophthalmol (2009) 1.02
High-dose humanized anti-IL-2 receptor alpha antibody (daclizumab) for the treatment of active, non-infectious uveitis. J Autoimmun (2008) 1.01
Hydrodynamic vaccination with DNA encoding an immunologically privileged retinal antigen protects from autoimmunity through induction of regulatory T cells. J Immunol (2007) 0.99
Biological response modifier therapy for refractory childhood uveitis. Br J Ophthalmol (2007) 0.97
Current approach in the diagnosis and management of panuveitis. Indian J Ophthalmol (2009) 0.94
Autoimmune and autoinflammatory mechanisms in uveitis. Semin Immunopathol (2014) 0.91
Biologic agents in inflammatory eye disease. J Ophthalmic Vis Res (2011) 0.90
Intravenous daclizumab for recalcitrant ocular inflammatory disease. Graefes Arch Clin Exp Ophthalmol (2009) 0.85
Long-term daclizumab therapy in relapsing-remitting multiple sclerosis. Ther Adv Neurol Disord (2009) 0.85
Cutaneous adverse events in multiple sclerosis patients treated with daclizumab. Neurology (2016) 0.83
An anti-interleukin-2 receptor drug attenuates T- helper 1 lymphocytes-mediated inflammation in an acute model of endotoxin-induced uveitis. PLoS One (2014) 0.83
Usefulness of adalimumab in the treatment of refractory uveitis associated with juvenile idiopathic arthritis. Mediators Inflamm (2013) 0.83
Long-term daclizumab therapy for the treatment of noninfectious ocular inflammatory disease. Can J Ophthalmol (2011) 0.80
[Uveitis in multiple sclerosis : Overview and perspectives]. Ophthalmologe (2014) 0.79
Retention time for corticosteroid-sparing systemic immunosuppressive agents in patients with inflammatory eye disease. Br J Ophthalmol (2006) 0.78
Review of Systemic Immunosuppression for Autoimmune Uveitis. Ophthalmol Ther (2014) 0.78
Longitudinal comparison of visual acuity as measured by the ETDRS chart and by the potential acuity meter in eyes with macular edema, and its relationship with retinal thickness and sensitivity. Eye (Lond) (2014) 0.78
Anti-TNFα agents and methotrexate in spondyloarthritis related uveitis in a Chinese population. Clin Rheumatol (2015) 0.77
Medical management of uveitis - current trends. Indian J Ophthalmol (2013) 0.77
Challenges of childhood uveitis. Sultan Qaboos Univ Med J (2009) 0.75
Ocular diseases: immunological and molecular mechanisms. Int J Ophthalmol (2016) 0.75
Biologic agents in experimental autoimmune uveitis. Int Ophthalmol (2013) 0.75
Targeted immunotherapy trials for idiopathic inflammatory myopathies. J Neurol (2012) 0.75
Intraocular tuberculosis--an update. Surv Ophthalmol (2007) 5.18
Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis. Sci Transl Med (2010) 4.95
Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis. Arch Ophthalmol (2011) 3.63
Ab interno trabeculectomy: development of a novel device (Trabectome) and surgery for open-angle glaucoma. J Glaucoma (2006) 2.91
Syphilis: reemergence of an old adversary. Ophthalmology (2006) 2.81
International criteria for the diagnosis of ocular sarcoidosis: results of the first International Workshop On Ocular Sarcoidosis (IWOS). Ocul Immunol Inflamm (2009) 2.47
Overall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive drugs: retrospective cohort study. BMJ (2009) 2.23
Plasmapheresis for lupus retinal vasculitis. Arch Ophthalmol (2006) 2.13
The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators. Arch Dermatol (2002) 2.10
Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature. Ann Allergy Asthma Immunol (2005) 2.01
Intraocular lymphoma. Curr Opin Ophthalmol (2002) 1.96
Methods for identifying long-term adverse effects of treatment in patients with eye diseases: the Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study. Ophthalmic Epidemiol (2008) 1.87
Clinical characteristics of a large cohort of patients with scleritis and episcleritis. Ophthalmology (2011) 1.85
Diagnosis of toxoplasmic retinochoroiditis with atypical clinical features. Am J Ophthalmol (2002) 1.75
Cyclosporine for ocular inflammatory diseases. Ophthalmology (2010) 1.75
Solitary fibrous tumor of the orbit: a clinicopathologic study of six cases with review of the literature. Surv Ophthalmol (2003) 1.73
Analysis of pediatric uveitis cases at a tertiary referral center. Ophthalmology (2005) 1.69
Relapsing polychondritis: a clinical review. Semin Arthritis Rheum (2002) 1.68
Intravitreal bevacizumab for treatment of uveitic macular edema. Ophthalmology (2007) 1.66
Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration. J Autoimmun (2003) 1.66
Nonsteroidal anti-inflammatory therapy and recurrent acute anterior uveitis. Ocul Immunol Inflamm (2010) 1.62
Adverse effects of smoking on patients with ocular inflammation. Br J Ophthalmol (2010) 1.61
Methotrexate for ocular inflammatory diseases. Ophthalmology (2009) 1.58
Long-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidence. Am J Ophthalmol (2008) 1.56
Ocular pemphigus. J Am Acad Dermatol (2005) 1.56
Association of herpesviruses in the aqueous humor of patients with serpiginous choroiditis: a polymerase chain reaction-based study. Ocul Immunol Inflamm (2002) 1.50
Vitreous cytokine levels. Ophthalmology (2003) 1.48
Recommendations for the reporting of tissues removed as part of the surgical treatment of common malignancies of the eye and its adnexa. Mod Pathol (2003) 1.44
Azathioprine for ocular inflammatory diseases. Am J Ophthalmol (2009) 1.44
Neoplastic masquerade syndromes. Surv Ophthalmol (2002) 1.42
Serpiginous choroiditis. Surv Ophthalmol (2005) 1.41
Mycophenolate mofetil for ocular inflammation. Am J Ophthalmol (2009) 1.41
International Uveitis Study Group (IUSG): clinical classification of uveitis. Ocul Immunol Inflamm (2008) 1.38
Anti-tubercular treatment is not required in latent tuberculosis. Br J Ophthalmol (2012) 1.38
Ocular tuberculosis: a clinicopathologic and molecular study. Ophthalmology (2010) 1.37
Punctate inner choroidopathy: a survey analysis of 77 persons. Ophthalmology (2007) 1.36
Etiology and management of idiopathic orbital inflammation. Am J Ophthalmol (2004) 1.33
Vogt-Koyanagi-Harada disease in patients with chronic hepatitis C. Am J Ophthalmol (2005) 1.31
Waldenström's macroglobulinemia-associated retinopathy. Ophthalmology (2004) 1.26
Vogt-Koyanagi-Harada disease. Int Ophthalmol Clin (2006) 1.25
Strengths and weaknesses of diagnostic tools for tuberculous uveitis. Ocul Immunol Inflamm (2009) 1.25
Review: orbital amyloidosis. Ophthal Plast Reconstr Surg (2004) 1.24
Presumed Vogt-Koyanagi-Harada disease with unilateral ocular involvement: report of three cases. Graefes Arch Clin Exp Ophthalmol (2009) 1.23
Interferon-gamma release assays in the diagnosis of tuberculous uveitis. Am J Ophthalmol (2008) 1.23
Ocular inflammation in Behçet disease: incidence of ocular complications and of loss of visual acuity. Am J Ophthalmol (2008) 1.23
Nontuberculous mycobacterial ocular and adnexal infections. Surv Ophthalmol (2012) 1.23
Upregulation of chemokine expression in the retinal vasculature in ischemia-reperfusion injury. Invest Ophthalmol Vis Sci (2003) 1.22
Ocular cicatricial pemphigoid: pathogenesis, diagnosis and treatment. Prog Retin Eye Res (2004) 1.20
Multifocal choroiditis and panuveitis: immunomodulatory therapy. Ophthalmology (2002) 1.20
Serpiginous choroiditis and infectious multifocal serpiginoid choroiditis. Surv Ophthalmol (2013) 1.19
Primary intraocular lymphoma: A review. Semin Ophthalmol (2006) 1.19
Acute posterior multifocal placoid pigment epitheliopathy: outcome and visual prognosis. Retina (2009) 1.19
A prospective evaluation of subconjunctival injection of triamcinolone acetonide for resistant anterior scleritis. Ophthalmology (2002) 1.18
360 degrees iris-ciliary body B-cell lymphoma masquerading as post-cataract uveitis. Semin Ophthalmol (2004) 1.18
Expression of chemokine receptors, CXCR4 and CXCR5, and chemokines, BLC and SDF-1, in the eyes of patients with primary intraocular lymphoma. Ophthalmology (2003) 1.17
High-dose methotrexate for intraocular lymphoma. Clin Cancer Res (2003) 1.15
Clinical features of tuberculous serpiginouslike choroiditis in contrast to classic serpiginous choroiditis. Arch Ophthalmol (2010) 1.15
Cyclophosphamide for ocular inflammatory diseases. Ophthalmology (2009) 1.14
Evaluation of the effect on outcomes of the route of administration of corticosteroids in acute Vogt-Koyanagi-Harada disease. Am J Ophthalmol (2006) 1.14
Role of collagen-binding heat shock protein 47 and transforming growth factor-beta1 in conjunctival scarring in ocular cicatricial pemphigoid. Invest Ophthalmol Vis Sci (2003) 1.14
Glaucoma and uveitis. Surv Ophthalmol (2012) 1.13
Long-term results of Ahmed glaucoma valve implantation for uveitic glaucoma. Am J Ophthalmol (2007) 1.12
Presumed trematode-induced granulomatous anterior uveitis: a newly recognized cause of intraocular inflammation in children from south India. Am J Ophthalmol (2002) 1.12
Intravitreal clindamycin for toxoplasmic retinochoroiditis. Retina (2007) 1.11
Spectral domain optical coherence tomography and autofluorescence in a case of acute posterior multifocal placoid pigment epitheliopathy mimicking Vogt-Koyanagi-Harada disease: case report and review of literature. Ocul Immunol Inflamm (2010) 1.09
Expression of vascular endothelial growth factor in eyes with Coats' disease. Invest Ophthalmol Vis Sci (2013) 1.09
Anterior segment optical coherence tomography. Semin Ophthalmol (2010) 1.09
Biologic response modifier therapy for psoriatic ocular inflammatory disease. Ocul Immunol Inflamm (2008) 1.09
Bartonella henselae infection presenting as a unilateral panuveitis simulating Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol (2004) 1.09
Local ischemia and increased expression of vascular endothelial growth factor following ocular dissemination of Mycobacterium tuberculosis. PLoS One (2011) 1.09
Strong associations between specific HLA-DQ and HLA-DR alleles and the tubulointerstitial nephritis and uveitis syndrome. Invest Ophthalmol Vis Sci (2003) 1.08
Work-up, diagnosis and management of acute Vogt-Koyanagi-Harada disease: a case of acute myopization with granulomatous uveitis. Int Ophthalmol (2007) 1.08
Long-term follow-up of patients with birdshot retinochoroidopathy treated with corticosteroid-sparing systemic immunomodulatory therapy. Ophthalmology (2005) 1.08
Mycophenolate mofetil as an immunomodulatory agent in the treatment of chronic ocular inflammatory disorders. Ophthalmology (2003) 1.07
Expression of glucocorticoid induced TNF receptor family related protein (GITR) on peripheral T cells from normal human donors and patients with non-infectious uveitis. J Autoimmun (2003) 1.07
Associations among visual acuity and vision- and health-related quality of life among patients in the multicenter uveitis steroid treatment trial. Invest Ophthalmol Vis Sci (2012) 1.07
Vogt-Koyanagi-Harada disease. Int Ophthalmol Clin (2005) 1.07
Scleritis therapy. Ophthalmology (2011) 1.07
Limbal stem cell transplantation in chronic inflammatory eye disease. Ophthalmology (2002) 1.07
Visual outcomes in children with juvenile idiopathic arthritis-associated uveitis. Ophthalmology (2006) 1.07
Clinical review: treatment of vitreoretinal lymphoma. Ocul Immunol Inflamm (2009) 1.06
Bilateral uveitis associated with fluoroquinolone therapy. Cutan Ocul Toxicol (2011) 1.05
Vogt-Koyanagi-Harada syndrome associated with bilateral serous macular detachments responsive to immunomodulatory therapy. Ophthalmic Surg Lasers Imaging (2009) 1.05
Sterile corneal melting and necrotizing scleritis after cataract surgery in patients with rheumatoid arthritis and collagen vascular disease. Semin Ophthalmol (2003) 1.04
Pegaptanib sodium for macular edema secondary to central retinal vein occlusion. Arch Ophthalmol (2009) 1.04
The Boston keratoprosthesis in Stevens-Johnson syndrome. Am J Ophthalmol (2008) 1.04
Risk of hypotony in noninfectious uveitis. Ophthalmology (2012) 1.03
Orbitotemporal neurofibromatosis: classification and treatment. Orbit (2007) 1.03
The spectrum of fundus autofluorescence findings in birdshot chorioretinopathy. J Ophthalmol (2010) 1.02
Risk of choroidal neovascularization among the uveitides. Am J Ophthalmol (2013) 1.02
Photoreceptor mitochondrial oxidative stress in early experimental autoimmune uveoretinitis. Br J Ophthalmol (2006) 1.02
Multiple sclerosis-associated uveitis. Ocul Immunol Inflamm (2004) 1.02
Subconjunctival bevacizumab for corneal neovascularization. Cornea (2008) 1.02
Ultra-wide-field green-light (532-nm) autofluorescence imaging in chronic Vogt-Koyanagi-Harada disease. Ophthalmic Surg Lasers Imaging (2011) 1.01
Infliximab therapy for the treatment of refractory ocular inflammatory disease. Arch Ophthalmol (2007) 1.01
Mycophenolate mofetil after methotrexate failure or intolerance in the treatment of scleritis and uveitis. Ophthalmology (2008) 1.01
Sympathetic ophthalmia following postoperative bacterial endophthalmitis: a clinicopathologic study. Am J Ophthalmol (2006) 1.01